BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
BBOT
31 hedge funds and large institutions have $186M invested in BridgeBio Oncology Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CC
Commodore Capital
New York
|
-$5.25M |
| 2 |
SFM
Soros Fund Management
New York
|
-$3.67M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
-$2.63M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.43M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.15M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1.56M | +$1M | +88,500 | +179% |
|
|
WP
27
Woodline Partners
San Francisco,
California
| $1.17M | – | – | – |
|
|
MCM
28
Moore Capital Management
New York
| $1.13M | – | – | – |
|
|
KPF
29
K2 Principal Fund
Toronto,
Ontario, Canada
| $1.13M | +$1.13M | +100,000 | New |
|
30
UBS Group
Zurich,
Switzerland
| $1.05M | +$652K | +57,712 | +165% |
|
31
Geode Capital Management
Boston,
Massachusetts
| $150K | – | – | – |
|
|
CC
32
Commodore Capital
New York
| – | -$5.25M | -500,000 | Closed |
|
|
AAA
33
Affinity Asset Advisors
New York
| – | -$2.63M | -250,000 | Closed |
|
|
GAM
34
Gritstone Asset Management
Bethesda,
Maryland
| – | -$259K | -24,666 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$10 | -1 | Closed |
|